Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Commercial FITs can match NG-MSDT diagnostic results for CRC by lowering the positivity threshold, enhancing sensitivity while maintaining specificity. FITs are accessible, noninvasive CRC screening ...

Take your FIT test at home. Do not take your test if you can see blood in your poop or if you had a recent colonoscopy that found polyps. Huntsman Cancer Institute and University of Utah Health ...

Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

ASCs are increasingly at the forefront of colorectal cancer prevention efforts, particularly as new screening technologies gain traction. Following two FDA approvals last year, many ASCs are stepping ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

INDIANAPOLIS -- A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas ...

Interval fecal immunochemical testing was positive in up to 17% of patients after colonoscopy regardless of polypectomy, ...

Some modern stool tests can detect around 92 percent of colorectal cancers. But colonoscopies can detect cancer -- and prevent it. Q: My doctor always encourages me to do a colonoscopy for colorectal ...

VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...

Roughly 10% of fecal immunochemical tests (FIT) used for colorectal cancer (CRC) screening by a safety-net health system contained unsatisfactory samples that could not be processed. And fewer than ...